Literature DB >> 3813676

IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis.

M Gioud-Paquet, M Auvinet, T Raffin, P Girard, M Bouvier, E Lejeune, J C Monier.   

Abstract

One hundred patients with rheumatoid arthritis (RA), of whom 73 were seropositive by latex or Waaler-Rose (WR) assays, or both, 100 healthy subjects, and 102 diseased controls (22 patients with systemic lupus erythematosus (SLE) and 80 with bronchial asthma) were evaluated for the presence of IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF by an enzyme linked immunosorbent assay (ELISA). Ninety two per cent, 65%, 68%, and 66% of the patients with RA were found to be positive for IgM, IgA, IgE, and IgG respectively. A positive correlation existed between the levels of IgM RF and IgA RF on the one hand and disease activity on the other, and the levels of IgM RF and IgA RF correlated with the levels of circulating immune complexes as measured by a C1q binding assay. The presence of extra-articular features also correlated positively with the levels of IgA RF and IgE RF. Five out of six patients with Sjögren's syndrome had very high levels of IgA RF. Of 47 patients typed for HLA-DR, DR1 and DR2 were significantly more frequent in those with the highest levels of IgM RF. Conversely, DR3 was associated with low levels or absence of IgA RF and IgE RF. These results suggest that immune response genes may regulate the level of different RF isotypes. The frequencies of IgM, IgA, IgE, and IgG RF were 59%, 36%, 9%, and 27% respectively in SLE and 25%, 2.5%, 70%, and 59% in bronchial asthma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3813676      PMCID: PMC1002060          DOI: 10.1136/ard.46.1.65

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  30 in total

1.  The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis.

Authors:  C M PLOTZ; J M SINGER
Journal:  Am J Med       Date:  1956-12       Impact factor: 4.965

2.  A simple enzyme immunoassay for the demonstration of rheumatoid factor.

Authors:  M Gripenberg; F Wafin; H Isomäki; E Linder
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

3.  ELISA for rheumatoid factor.

Authors:  F T Willems; C C Klaasen de Kort
Journal:  Lancet       Date:  1978-05-06       Impact factor: 79.321

4.  Enzyme-linked immunosorbent assay for determination of IgM rheumatoid factor.

Authors:  M Vejtorp; M Høier-Madsen; P Halberg
Journal:  Scand J Rheumatol       Date:  1979       Impact factor: 3.641

5.  IgG-, IgM- and IgA-rheumatoid factors in healthy adults and rheumatoid patients determined by an indirect immunofluorescence method.

Authors:  H E Kallerup; E M Egeskjold; H Graudal
Journal:  Scand J Rheumatol       Date:  1979       Impact factor: 3.641

6.  Quantitative determination of rheumatoid factor by an enzyme-labeled immunoassay.

Authors:  J Karsh; S P Halbert; E Klima; A D Steinberg
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

7.  A quantitative enzyme immunoassay for IgM rheumatoid factor using human immunoglobulin G as substrate.

Authors:  S P Halbert; J Karsh; M Anken
Journal:  Am J Clin Pathol       Date:  1980-12       Impact factor: 2.493

8.  Rheumatoid arthritis and B lymphocyte alloantigen HLA-DRw4.

Authors:  O Scherak; J S Smolen; W R Mayr
Journal:  J Rheumatol       Date:  1980 Jan-Feb       Impact factor: 4.666

9.  IgG rheumatoid factor. Relationship to seropositive rheumatoid arthritis and absence in seronegative disorders.

Authors:  R M Pope; S J McDuffy
Journal:  Arthritis Rheum       Date:  1979-09

10.  Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.

Authors:  G S Panayi; P Wooley; J R Batchelor
Journal:  Br Med J       Date:  1978-11-11
View more
  30 in total

1.  Detection of antiendothelial cell antibodies by an enzyme-linked immunosorbent assay using antigens from cell lysate: minimal interference with antinuclear antibodies and rheumatoid factors.

Authors:  Christian Drouet; Marie-France Nissou; Denise Ponard; Josiane Arvieux; Chantal Dumestre-Pérard; Philippe Gaudin; Bernard Imbert; Christian Massot; Françoise Sarrot-Reynauld
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

Review 2.  Rheumatoid arthritis, malignancy, and paraproteins.

Authors:  C Kelly; H Sykes
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

3.  Effects of rheumatoid factor isotypes on disease activity and severity in patients with rheumatoid arthritis: a comparative study.

Authors:  Aşkin Ateş; Gülay Kinikli; Murat Turgay; Gülay Akay; Güner Tokgöz
Journal:  Clin Rheumatol       Date:  2006-06-28       Impact factor: 2.980

4.  No interference of rheumatoid factor(s) with toxoplasmosis IgM determination in infancy.

Authors:  O Djurković-Djaković; N Milosević-Jovcić; S Zerjav; D Sibalić
Journal:  Eur J Pediatr       Date:  1992-01       Impact factor: 3.183

5.  IgM rheumatoid factor in congenital syphilis: associations with clinical and laboratory findings.

Authors:  M P Meyer; D W Beatty
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

6.  Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis.

Authors:  L Vasiliauskiene; A Wiik; M Høier-Madsen
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

7.  Complement C4 monitoring in the follow-up of chronic hepatitis C treatment.

Authors:  C Dumestre-Perard; D Ponard; C Drouet; V Leroy; J-P Zarski; N Dutertre; M G Colomb
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

8.  Determination of IgA- and IgM-rheumatoid factors in patients with rheumatoid arthritis with and without nephropathy.

Authors:  M Nakano; M Ueno; S Nishi; S Suzuki; H Hasegawa; T Watanabe; T Kuroda; S Ito; M Arakawa
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

9.  Significance of rheumatoid factor isotypes in seronegative rheumatoid arthritis.

Authors:  F Eggelmeijer; H G Otten; H H de Rooy; M R Daha; F C Breedveld
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

10.  Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins.

Authors:  Katleen Van Steendam; Kelly Tilleman; Marlies De Ceuleneer; Filip De Keyser; Dirk Elewaut; Dieter Deforce
Journal:  Arthritis Res Ther       Date:  2010-07-07       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.